Publications

Detailed Information

Diagnostic Usefulness of a T-cell-based Assay for Extrapulmonary Tuberculosis in Immunocompromised Patients

DC Field Value Language
dc.contributor.authorKim, Sung-Han-
dc.contributor.authorSong, Kyoung-Ho-
dc.contributor.authorChoi, Su-Jin-
dc.contributor.authorKim, Hong-Bin-
dc.contributor.authorOh, Myoung-don-
dc.contributor.authorChoe, Kang-Won-
dc.contributor.authorKim, Nam-Joong-
dc.date.accessioned2012-05-24T01:42:49Z-
dc.date.available2012-05-24T01:42:49Z-
dc.date.issued2009-02-
dc.identifier.citationAMERICAN JOURNAL OF MEDICINE; Vol.122 2; 189-195ko_KR
dc.identifier.issn0002-9343-
dc.identifier.urihttps://hdl.handle.net/10371/76381-
dc.description.abstractBACKGROUND: The low reactivity of the tuberculin skin test limits its clinical use in immunocompromised patients with extrapulmonary tuberculosis. A recently developed T-cell-based assay for diagnosing tuberculosis infection gave promising results. However, there were few data on the usefulness of this assay for diagnosing extrapulmonary tuberculosis in immunocompromised patients. METHODS: All adult patients with suspected extrapulmonary tuberculosis were prospectively enrolled at 2 university-affiliated hospitals over an 18-month period. In addition to the conventional tests for diagnosing extrapulmonary tuberculosis, enzyme-linked immunospot (ELISPOT) assay for the interferon-gamma-producing T-cell response to early secretory antigenic target-6 and culture filtrate protein-10 was performed. The final diagnoses in patients with suspected extrapulmonary tuberculosis were classified by clinical category. RESULTS: There were 179 patients with suspected extrapulmonary tuberculosis enrolled: 59 (33%) were classified as immunocompromised. Of the 179 patients, 75 (42%) were classified as extrapulmonary tuberculosis, including 56 confirmed tuberculosis plus 19 probable tuberculosis, and 97 (54%) were classified as not tuberculosis. The remaining 7 (4%) had possible tuberculosis and were excluded from the final analysis. The tuberculin skin test (induration size >= 10 mm) was less sensitive in immunocompromised patients (38%; 95% confidence interval [CI], 19%-59%) than in immunocompetent patients (69%; 95% CI, 54%-81%, P = .01). In contrast, the ELISPOT assay retained a high sensitivity: (88%; 95% CI, 68%-97%) in immunocompromised patients compared with 96% (95% CI, 87%-100%) in immunocompetent patients (P = .32). CONCLUSION: The immunosuppressive condition does not affect the diagnostic sensitivity of the ELISPOT assay for extrapulmonary tuberculosis. (C) 2009 Elsevier Inc. All rights reserved. . The American Journal of Medicine (2009) 122, 189-195ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE INCko_KR
dc.subjectELISPOTko_KR
dc.subjectTuberculosisko_KR
dc.subjectImmunocompromisedko_KR
dc.titleDiagnostic Usefulness of a T-cell-based Assay for Extrapulmonary Tuberculosis in Immunocompromised Patientsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김성한-
dc.contributor.AlternativeAuthor송경호-
dc.contributor.AlternativeAuthor최수진-
dc.contributor.AlternativeAuthor김홍빈-
dc.contributor.AlternativeAuthor오명돈-
dc.contributor.AlternativeAuthor최강원-
dc.contributor.AlternativeAuthor김남중-
dc.identifier.doi10.1016/j.amjmed.2008.07.028-
dc.citation.journaltitleAMERICAN JOURNAL OF MEDICINE-
dc.description.citedreferenceThomas MM, 2008, INT J TUBERC LUNG D, V12, P651-
dc.description.citedreferenceKim SH, 2007, ARCH INTERN MED, V167, P2255-
dc.description.citedreferenceKobashi Y, 2007, EUR RESPIR J, V30, P945, DOI 10.1183/09031936.00040007-
dc.description.citedreferenceChee CBE, 2007, AM J RESP CRIT CARE, V175, P282, DOI 10.1164/rccm.200608-1109OC-
dc.description.citedreferenceDewan PK, 2007, CLIN INFECT DIS, V44, P69-
dc.description.citedreferenceGoletti D, 2006, J INFECT DIS, V194, P984-
dc.description.citedreferenceLee JY, 2006, EUR RESPIR J, V28, P24, DOI 10.1183/09031936.06.00016906-
dc.description.citedreferenceFerrara G, 2006, LANCET, V367, P1328-
dc.description.citedreferenceWilkinson KA, 2006, J INFECT DIS, V193, P354-
dc.description.citedreferenceDheda K, 2005, AIDS, V19, P2038-
dc.description.citedreferencePolesky A, 2005, MEDICINE, V84, P350, DOI 10.1097/01.md.0000189090.52626.7a-
dc.description.citedreferenceMeier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8-
dc.description.citedreferenceKang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756-
dc.description.citedreferenceBrodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012-
dc.description.citedreferenceNicol MP, 2005, CLIN INFECT DIS, V40, P1301-
dc.description.citedreferenceLiebeschuetz S, 2004, LANCET, V364, P2196-
dc.description.citedreferencePai M, 2004, LANCET INFECT DIS, V4, P761-
dc.description.citedreferenceCinar F, 2003, OTOLARYNG HEAD NECK, V129, P245, DOI 10.1016/S0194-5998(03)00146-3-
dc.description.citedreferenceKeane J, 2001, NEW ENGL J MED, V345, P1098-
dc.description.citedreferenceLalvani A, 2001, AM J RESP CRIT CARE, V163, P824-
dc.description.citedreferenceCANTWELL MF, 1994, JAMA-J AM MED ASSOC, V272, P535-
dc.description.citedreferenceHUEBNER RE, 1993, CLIN INFECT DIS, V17, P968-
dc.description.citedreferenceMEHTA JB, 1991, CHEST, V99, P1134-
dc.description.citedreferenceALTMAN DG, 1991, PRACTICAL STAT MED R, P397-
dc.description.tc32-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share